Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07389226 · ClinicalTrials.gov registry record · NA
The Effect of Apple Cider Vinegar Supplementation on 24-hour Urine Chemistry in Adults
A NA study, sponsored by University of Chicago.
- Not yet
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT07389226: Clinical Trial NA study, sponsored by University of Chicago.
NCT07389226 is a NA study that has not yet begun recruiting, run by University of Chicago. The registered enrollment target is 30 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07389226, a NA study, has not yet begun recruiting, sponsored by University of Chicago.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
This is a single-center prospective cohort study to evaluate the effect of short-term daily apple cider vinegar (ACV) supplementation on urine chemistry.
Primary Outcome
to evaluate the effect of short-term daily apple cider vinegar (ACV) supplementation on urine chemistry.
Interventions
- DIETARY_SUPPLEMENT Apple Cider Vinegar
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2026-12 |
| Est. Completion | 2028-02 |
| Phase | NA |
What is known before NCT07389226 opens enrollment
NCT07389226 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which Apple Cider Vinegar is the first listed.
NCT07389226 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07389226 about?
NCT07389226 is a clinical study titled "The Effect of Apple Cider Vinegar Supplementation on 24-hour Urine Chemistry in Adults". This is a single-center prospective cohort study to evaluate the effect of short-term daily apple cider vinegar (ACV) supplementation on urine chemistry.
What is the current status of trial NCT07389226?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2026-12. Estimated completion is 2028-02.
What interventions are being tested in trial NCT07389226?
The interventions under investigation include: Apple Cider Vinegar (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT07389226?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07389226's enrollment target sits among peer trials
30 1593rd of 2000 higher than 299 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia